(Q37996827)

26 August 2017

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension (English)

1 reference

26 August 2017

0 references

arterial hypertension

0 references

5

Steeve Provencher

1 reference

26 August 2017

Marjorie Barrier

1

1 reference

26 August 2017

Jolyane Meloche

2

1 reference

26 August 2017

Maria Helena Jacob

3

1 reference

26 August 2017

Audrey Courboulin

4

1 reference

26 August 2017

Sébastien Bonnet

6

1 reference

26 August 2017

25 March 2012

1 reference

Cellular and Molecular Life Sciences

26 August 2017

1 reference

26 August 2017

69

1 reference

26 August 2017

17

1 reference

26 August 2017

2805-2831

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-012-0950-4

26 August 2017

0 references

cites work

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Risk factors for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Imaging of the heart in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Clinical challenges in pulmonary hypertension: Roger S. Mitchell lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Primary pulmonary hypertension: Current therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Medical management of primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Goal-oriented treatment and combination therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

MicroRNAs play an essential role in the development of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Nocturnal hypoxemia is common in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Effects of inhaled salbutamol in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary function in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Exercise pathophysiology in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Guidelines for the diagnosis and treatment of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

The role of echocardiography in hemodynamic assessment in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prognostic impact of right ventricular involvement as assessed by tricuspid annular motion in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Tricuspid annular displacement predicts survival in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Assessment of right ventricular function by strain rate imaging in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Quantitative three dimensional echocardiography in patients with pulmonary hypertension and compressed left ventricles: comparison with cross sectional echocardiography and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Right ventricular function assessed by two-dimensional strain and tissue Doppler echocardiography in patients with pulmonary arterial hypertension and effect of vasodilator therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary hypertension findings detected by F-18 FDG PET scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Synthesis, radiolabeling and in vivo evaluation of [11C]RAL-01, a potential phosphodiesterase 5 radioligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

A single, comprehensive non-invasive cardiovascular assessment in pulmonary arterial hypertension: combined computed tomography pulmonary and coronary angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Low-dose ECG-gated 64-slices helical CT angiography of the chest: evaluation of image quality in 105 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Material differentiation by dual energy CT: initial experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Dual energy CT for the assessment of lung perfusion--correlation to scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Assessment of pulmonary hypertension by CT and MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

End points and clinical trial design in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Measurement of right ventricular mass in normal and dilated cardiomyopathic ventricles using cine magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Early diagnosis of cor pulmonale with MR imaging of the right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Assessment of right ventricular diastolic and systolic function in patients with dilated cardiomyopathy using cine magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography--preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Dynamic perfusion MRI: capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary hypertension: pulmonary flow quantification and flow profile analysis with velocity-encoded cine MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

NT-proBNP reflects right ventricular structure and function in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Nitric oxide and cyclic GMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Urinary cGMP concentrations in severe primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Significance of a plasma D-dimer test in patients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Elevation of ELISA d-dimer levels in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Sitaxsentan therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

An integrated approach for experimental target identification of hypoxia-induced miR-210

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxidative stress in severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased lipid peroxidation in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Superoxide in the pulmonary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Biological serum markers in the management of pediatric pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

IPF2alpha-I: an index of lipid peroxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Isoprostanes and lung vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased plasma serotonin in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Nitric oxide as a cellular antioxidant: a little goes a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxygen-dependent and -independent regulation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Signal transduction to hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Potential diagnostic biomarkers in serum of idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Endothelin-1 in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension

21 January 2018

1 reference

12 December 2020

Osteopontin in Patients With Idiopathic Pulmonary Hypertension

1 reference

12 December 2020

Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased

1 reference

12 December 2020

Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion

1 reference

12 December 2020

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension

1 reference

12 December 2020

Hemodynamic correlates of exercise function in patients with primary pulmonary hypertension

1 reference

12 December 2020

Endothelin-1 and O2-mediated pulmonary hypertension in neonatal rats: a role for products of lipid peroxidation

1 reference

12 December 2020

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

1 reference

12 December 2020

Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension

1 reference

12 December 2020

Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha

1 reference

12 December 2020

Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis

1 reference

12 December 2020

The roles of bcl-2 gene family in the pulmonary artery remodeling of hypoxia pulmonary hypertension in rats.

1 reference

12 December 2020

Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

1 reference

12 December 2020

PPARgamma and the pathobiology of pulmonary arterial hypertension

1 reference

12 December 2020

Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Assessment of pulmonary hypertension what CT and MRI can provide

1 reference

12 December 2020

Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation

1 reference

12 December 2020

Hyperuricemia in severe pulmonary hypertension

1 reference

12 December 2020

Role for miR-204 in human pulmonary arterial hypertension

1 reference

12 December 2020

Antinuclear antibodies in primary pulmonary hypertension

1 reference

12 December 2020

Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension

1 reference

12 December 2020

Cellular antioxidant and pro-oxidant actions of nitric oxide

1 reference

12 December 2020

End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives

1 reference

12 December 2020

Strain and strain rate echocardiography for evaluation of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension.

1 reference

12 December 2020

Analysis of circulating microRNA: preanalytical and analytical challenges.

1 reference

12 December 2020

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Perspective on the optimal endpoints for pulmonary arterial hypertension trials

1 reference

12 December 2020

Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis

1 reference

12 December 2020

Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension

1 reference

12 December 2020

MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration

1 reference

12 December 2020

Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure

1 reference

12 December 2020

Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung

1 reference

12 December 2020

Endothelin-1/Endothelin-3 Ratio

1 reference

12 December 2020

Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy.

1 reference

12 December 2020

Prognostic and predictive potential molecular biomarkers in colon cancer.

1 reference

12 December 2020

Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy

1 reference

12 December 2020

Contemporary issues in pulmonary hypertension

1 reference

12 December 2020

Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma

1 reference

12 December 2020

Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat

1 reference

12 December 2020

Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group

1 reference

12 December 2020

Reduction of claustrophobia during magnetic resonance imaging: methods and design of the "CLAUSTRO" randomized controlled trial

1 reference

12 December 2020

Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.

1 reference

12 December 2020

Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+

1 reference

12 December 2020

Increased sympathetic nerve activity in pulmonary artery hypertension

1 reference

12 December 2020

Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment

1 reference

12 December 2020

Antioxidant and oxidative stress changes in experimental cor pulmonale

1 reference

12 December 2020

Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease.

1 reference

12 December 2020

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1 reference

12 December 2020

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group

1 reference

12 December 2020

Dobutamine-induced increase of right ventricular contractility without increased stroke volume in adolescent patients with transposition of the great arteries: evaluation with magnetic resonance imaging

1 reference

12 December 2020

1 reference

12 December 2020

Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination

1 reference

12 December 2020

Cardiac troponin I as diagnostic and prognostic marker in severe heart failure

1 reference

12 December 2020

GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells

1 reference

12 December 2020

Assessment of cross-sectional lung ventilation-perfusion imbalance in primary and passive pulmonary hypertension with automated V/Q SPECT

1 reference

12 December 2020

Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression

1 reference

12 December 2020

The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography

1 reference

12 December 2020

Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.

1 reference

12 December 2020

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

1 reference

12 December 2020

Pulmonary hypertension

1 reference

12 December 2020

Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia

1 reference

12 December 2020

Therapie der pulmonal arteriellen Hypertonie (PAH)

1 reference

12 December 2020

Circulating biomarkers of tissue remodelling in pulmonary hypertension.

1 reference

12 December 2020

Noninvasive assessment of right ventricular function: will there be resurgence in radionuclide imaging techniques?

1 reference

12 December 2020

Serum concentration of cardiac troponin T in patients with cardiomyopathy: a possible mechanism of acute heart failure.

1 reference

12 December 2020

Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension

1 reference

12 December 2020

Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.

1 reference

12 December 2020

[Cellular markers based on DNA damage and repair (BER, MMR), expression of MLHI, MSH2, FasR, and cell death of lymphocytes as predictive parameters for clinical response to chemotherapy of melanoma]

1 reference

12 December 2020

D-dimer and pulmonary arterial hypertension in systemic sclerosis

1 reference

12 December 2020

Early stages of mesothelioma, screening and biomarkers

1 reference

12 December 2020

Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension

1 reference

12 December 2020

A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension

1 reference

12 December 2020

Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia

1 reference

12 December 2020

Biochemical markers in the management of pulmonary hypertension.

1 reference

12 December 2020

Impaired stroke volume response to exercise in pulmonary arterial hypertension

1 reference

12 December 2020

CT findings in diseases associated with pulmonary hypertension: a current review

1 reference

12 December 2020

Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension

1 reference

12 December 2020

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

1 reference

12 December 2020

Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients

1 reference

12 December 2020

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension

1 reference

12 December 2020

Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation.

1 reference

12 December 2020

[Imaging of pulmonary arterial hypertension.]

1 reference

12 December 2020

Exercise testing to estimate survival in pulmonary hypertension

1 reference

12 December 2020

Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats

1 reference

12 December 2020

Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species

1 reference

12 December 2020

A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension

1 reference

12 December 2020

Left ventricular structure and function for postmyocardial infarction and heart failure risk stratification by three-dimensional echocardiography

1 reference

12 December 2020

MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities

1 reference

12 December 2020

Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice

1 reference

12 December 2020

From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension

1 reference

12 December 2020

Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study

1 reference

12 December 2020

Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation

1 reference

12 December 2020

Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Endothelin-1 is elevated in monocrotaline pulmonary hypertension.

1 reference

12 December 2020

Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension

1 reference

12 December 2020

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline

1 reference

12 December 2020

Diagnosis and evaluation of pulmonary hypertension

1 reference

12 December 2020

Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension

1 reference

12 December 2020

Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension

1 reference

12 December 2020

Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension

1 reference

12 December 2020

Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension

1 reference

12 December 2020

Protein carbonylation as a novel mechanism in redox signaling

1 reference

12 December 2020

Clinical classification of pulmonary hypertension.

1 reference

12 December 2020

Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension

1 reference

12 December 2020

Superoxide as an intermediate signal for serotonin-induced mitogenesis

1 reference

12 December 2020

Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.

1 reference

12 December 2020

REVEAL Registry: Correlation of Right Heart Catheterization and Echocardiography in Patients With Pulmonary Arterial Hypertension

1 reference

12 December 2020

Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization.

1 reference

12 December 2020

Diagnostics in pulmonary hypertension.

1 reference

12 December 2020

The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension.

1 reference

12 December 2020

Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension

1 reference

12 December 2020

10.1007/S00018-012-0950-4

Identifiers

DOI

1 reference

26 August 2017

1 reference